1. Home
  2. SVCO vs CDXS Comparison

SVCO vs CDXS Comparison

Compare SVCO & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVCO
  • CDXS
  • Stock Information
  • Founded
  • SVCO 1984
  • CDXS 2002
  • Country
  • SVCO United States
  • CDXS United States
  • Employees
  • SVCO N/A
  • CDXS N/A
  • Industry
  • SVCO
  • CDXS Major Chemicals
  • Sector
  • SVCO
  • CDXS Industrials
  • Exchange
  • SVCO NYSE
  • CDXS Nasdaq
  • Market Cap
  • SVCO 221.9M
  • CDXS 230.3M
  • IPO Year
  • SVCO 2024
  • CDXS 2010
  • Fundamental
  • Price
  • SVCO $4.33
  • CDXS $2.13
  • Analyst Decision
  • SVCO Strong Buy
  • CDXS Buy
  • Analyst Count
  • SVCO 6
  • CDXS 2
  • Target Price
  • SVCO $20.50
  • CDXS $11.00
  • AVG Volume (30 Days)
  • SVCO 113.0K
  • CDXS 1.1M
  • Earning Date
  • SVCO 05-14-2025
  • CDXS 05-01-2025
  • Dividend Yield
  • SVCO N/A
  • CDXS N/A
  • EPS Growth
  • SVCO N/A
  • CDXS N/A
  • EPS
  • SVCO N/A
  • CDXS N/A
  • Revenue
  • SVCO $59,680,000.00
  • CDXS $59,345,000.00
  • Revenue This Year
  • SVCO $18.77
  • CDXS $12.62
  • Revenue Next Year
  • SVCO $16.01
  • CDXS $22.11
  • P/E Ratio
  • SVCO N/A
  • CDXS N/A
  • Revenue Growth
  • SVCO 10.02
  • CDXS N/A
  • 52 Week Low
  • SVCO $3.55
  • CDXS $1.90
  • 52 Week High
  • SVCO $21.59
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • SVCO N/A
  • CDXS 36.76
  • Support Level
  • SVCO N/A
  • CDXS $2.05
  • Resistance Level
  • SVCO N/A
  • CDXS $2.47
  • Average True Range (ATR)
  • SVCO 0.00
  • CDXS 0.22
  • MACD
  • SVCO 0.00
  • CDXS 0.02
  • Stochastic Oscillator
  • SVCO 0.00
  • CDXS 28.40

About SVCO SILVACO GROUP INC

Silvaco Group Inc is a provider of technology computer aided design ("TCAD") software, electronic data automation ("EDA") software and semiconductor intellectual property ("SIP"). TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their products' time-to-market and reduce their development and manufacturing costs. It is developing the "technology behind the chip" and providing solutions that span from atoms to systems, starting with providing software for the atomic level simulation of semiconductor and photonics material for devices, to providing software and SIP for the design and analysis of circuits and system level solutions.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: